EHRA Premium Access

Risk calculators in arrhythmias: are they useful?

Event: EHRA 2022
Topic: Genetic Aspects of Arrhythmias
Session type: Guidelines in Practice
Date: 4 April 2022
Time: 15:55 - 16:55

Session

Become an EHRA member to access this resource

Become a member

Already a member? Sign in

5 presentations in this session

Genetic risk calculators.

Speaker: Doctor R. Tadros (Montreal, CA)
Thumbnail

HCM: who should get an implantable cardioverter defibrillator in Europe and the US in 2022?

Speaker: Professor P. Elliott (London, GB)
Thumbnail

LQTS: how to use the novel calculator.

Speaker: Doctor H. Tan (Amsterdam, NL)
Thumbnail

ARVC in 2021: do we implant the right patients?

Speaker: Professor P. Lambiase (London, GB)
Thumbnail

Risk calculators in arrhythmias: are they useful? - discussion.

Thumbnail

4 speakers from this session

Doctor Rafik Tadros

Montreal Heart Institute, Montreal (Canada)
1 presentation
0 follower

Professor Perry Mark Elliott

University College London, London (United Kingdom of Great Britain & Northern Ireland)
26 presentations
3 followers

Doctor Hanno Tan

University of Amsterdam, Amsterdam (Netherlands (The))
6 presentations
0 follower

Professor Pier Lambiase

University College London, London (United Kingdom of Great Britain & Northern Ireland)
12 presentations
0 follower

Related content

ESC Premium Access

Myocarditis associated with COVID vaccines

4 December 2021

ESC Premium Access

Controversy: can we propose atrial fibrillation ablation as first line therapy?

4 December 2021

ESC Premium Access

Current controversies in antithrombotic therapy

3 December 2021

This platform is supported by

logo Novo Nordisk